The CBO estimated that the Pelosi drug pricing reform legislation proposed would save Medicare $345 billion over seven years. It failed to look at the long-term effect on new drug discovery and the impact on population health.
Other featured articles
Young People Treated in Pediatric Emergency Departments Less Likely to Receive Opioids Compared to Similar Patients Treated in General EDs
Since the 1990s, children, adolescents, and young adults have also experienced dramatic increases in exposure to and harms from prescription opioids.
Accounting for Hope: Using ‘Mean Survival Gain’ to Price New Cancer Drugs
Outrage about the rising prices of prescription drugs has put cancer drugs in the spotlight. But there’s an important question that needs to be asked: What is the best pricing metric to use for them?
State Drug Pricing Transparency Laws: Numerous Efforts, Most Fall Short
166 recently enacted prescription drug pricing laws were analyzed to identify those that contained price transparency measures. Of these, 35 bills in 22 states include a transparency component, but only 7 were deemed to be informative.
Losing Summer: 10 Months. Nearly 30 Visits to San Francisco’s Psychiatric ER. And a Suicide
Summer’s story reveals the weaknesses in San Francisco’s mental illness and addiction treatment system.Posted in
The Leonard D. Schaeffer Center for Health Policy & Economics, one of the nation’s premier policy centers, measurably improves value in health through evidence-based policy solutions, research and educational excellence, and private- and public-sector engagement.about
More from Schaeffer
Our Initiatives & Centers
Learn about our collaborative efforts to inform the national healthcare debate, mitigate the consequences of health disparities, and examine cost and accessibility of care.Learn More
Work & Study at USC
The Schaeffer Center develops innovators for positions in higher education, research, government and healthcare through degree programs and postgraduate opportunities.Learn More
Seminar Series: Tuba TuncelTuba Tuncel will present on Tuesday, Oct. 22, 2019, at 2 p.m., on "Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France."Date of event:
Seminar Series: Ritika Chaturvedi, PhDRitika Chaturvedi will present on Tuesday, Oct. 29, 2019, at 2 p.m.Date of event:
Seminar Series: Aaron KleinAaron Klein will present on Tuesday, Nov. 5, 2019, at 2 p.m.Date of event: